美国 - 英文 - NLM (National Library of Medicine)

bryant ranch prepack - methenamine mandelate (unii: 695n30cinr) (methenamine - unii:j50oix95qv) - methenamine mandelate, usp is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also those neurologic diseases leading to an infected residual urine. when used as recommended, methenamine mandelate, usp is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop. pathogens resistant to other antibacterial agents may respond to methenamine mandelate, usp because of the nonspecific effect of formaldehyde formed in an acid urine. to reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine mandelate, usp and other antibacterial drugs, methenamine mandelate, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. prophylactic use rationale:  urine is a good culture medium for many urinary pathogens. inocul

美国 - 英文 - NLM (National Library of Medicine)

chartwell rx, llc - methenamine mandelate (unii: 695n30cinr) (methenamine - unii:j50oix95qv) - methenamine mandelate is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also those neurologic diseases leading to an infected residual urine. when used as recommended, methenamine mandelate is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop. pathogens resistant to other antibacterial agents may respond to methenamine mandelate because of the nonspecific effect of formaldehyde formed in an acid urine. prophylactic use rationale:  urine is a good culture medium for many urinary pathogens. inoculation by a few organisms (relapse or reinfection) may lead to bacteriuria in susceptible individuals. thus, the rationale of management in recurring urinary tract infection (bacteriuria) is to change the urine from a growth-supporting to a growth-inhibiting medium. there is a growing body of evidence that long-te

加拿大 - 英文 - Health Canada

searchlight pharma inc - methenamine mandelate - tablet - 500mg - methenamine mandelate 500mg - urinary anti-infectives

美国 - 英文 - NLM (National Library of Medicine)

imprimisrx pa, inc. d/b/a imprimisrx - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w), leucovorin calcium (unii: rpr1r4c0p4) (leucovorin - unii:q573i9dvlp) - pyrimethamine 12.5 mg

美国 - 英文 - NLM (National Library of Medicine)

amol pharmaceuticals private limited - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv) - methenamine 162 mg

美国 - 英文 - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - methenamine hippurate (unii: m329791l57) (methenamine - unii:j50oix95qv) - methenamine hippurate tablets, usp are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. this drug should only be used after eradication of the infection by other appropriate antimicrobial agents. to reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine hippurate tablets, usp and other antibacterial drugs, methenamine hippurate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. methenamine hippurate tablets, usp are contraindicated in patients with renal insufficiency, severe hepatic insufficiency, or severe dehydration. methe

美国 - 英文 - NLM (National Library of Medicine)

dr.reddys laboratories inc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

美国 - 英文 - NLM (National Library of Medicine)

alvogen inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

美国 - 英文 - NLM (National Library of Medicine)

fera pharmaceuticals, llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

美国 - 英文 - NLM (National Library of Medicine)

teva pharmaceuticals, inc. - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis : pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.